Skip to main content
OpenTrials

Clinical trial condition

Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

Explore clinical trials studying Congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Congenital adrenal hyperplasia due to 21 hydroxylase deficiency trial results

Recruiting

Natural History Study of Patients With Excess Androgen

NCT00250159

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenal Insufficiency, +21 more
Locations
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia

NCT02804178

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +17 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)

NCT04806451

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +17 more
Locations
  • Neurocrine Clinical Site Birmingham, Alabama, United States
  • Neurocrine Clinical Site Los Angeles, California, United States
  • Neurocrine Clinical Site Orange, California, United States
  • Neurocrine Clinical Site San Diego, California, United States
View all 46 locations
View Trial Details

Related conditions